CALY-001

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCALY-001

Drug Alias NameGastrointestinal disorder antibody therapeutics - Calypso BiotechGastrointestinal immunological disease therapeutics - Calypso BiotechCALY-001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionMatrix metalloproteinase 9 inhibitors

TargetsMatrix metalloproteinase 9

Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesCalypso Biotech Bv

China Registration ClassN/A

Develop Information

Active CompaniesCalypso Biotech Bv

Inactive CompaniesN/A

Active IndicationsCrohn DiseaseInflammatory Bowel Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A